Compare AUXX & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUXX | MLAB |
|---|---|---|
| Founded | N/A | 1982 |
| Country | Canada | United States |
| Employees | 26 | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.7M | 719.9M |
| IPO Year | 2026 | 1995 |
| Metric | AUXX | MLAB |
|---|---|---|
| Price | $4.08 | $128.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.94 | ★ $117.50 |
| AVG Volume (30 Days) | 12.3K | ★ 79.6K |
| Earning Date | 11-27-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | N/A | $6.45 |
| P/E Ratio | ★ N/A | $261.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.07 | $69.51 |
| 52 Week High | $6.16 | $144.35 |
| Indicator | AUXX | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 22.76 | 50.81 |
| Support Level | N/A | $120.65 |
| Resistance Level | $4.88 | $132.70 |
| Average True Range (ATR) | 0.25 | 4.66 |
| MACD | -0.02 | -0.47 |
| Stochastic Oscillator | 14.14 | 26.63 |
Gold X2 Mining Inc is a gold-focused Canadian mineral exploration company. Its primary business is the acquisition and exploration of precious metal mineral properties in Canada. Gold X2 currently holds title to the Moss Gold Project, Hillcrest Project, and an option to earn into the Vanguard Project, Coldstream Project, and Huronian Project located in Ontario, Canada.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.